4.6 Article Proceedings Paper

Results in surgery for primary and metastatic chest wall tumors

Journal

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
Volume 19, Issue 5, Pages 584-588

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S1010-7940(01)00638-8

Keywords

chest wall resection; breast cancer; renal cell carcinoma; sarcoma; aggressive fibromatosis; long-term survival

Ask authors/readers for more resources

Objectives: Resection of chest wall tumors is often indicated for palliation from pain or chronic ulceration. However, under various conditions, it may lead to lasting tumor control and substantial freedom of disease might be achieved. Therefore, the long-term survival after chest wall resection for primary and metastatic tumors and its relation to the underlying histology was analyzed. Methods: The medical files of 82 consecutive patients with tumors of the chest wall operated between 1 January 1989 and 31 October 1998 were reviewed. Follow-up data were collected from the outpatient's clinic and house physicians, respectively. Complete excision was accomplished in 71 patients. In 19 patients, partial or complete resection of the sternum was performed. Twenty-eight patients underwent chest wall resection extending to intrathoracic structures (lung, diaphragm, pericardium). The following subgroups were defined according to the histology: (A), sarcoma (n = 32); (B), breast cancer (n = 22); (C), renal cell cancer (n = 9); (D), other metastases (n = 7); (E), miscellaneous (n = 12). The survival probability was calculated by the Kaplan-Meier method (SAS software system). Results: One of 41 female patients died from postoperative complications on day 30 after resection of ulcerating breast cancer recurrence (hospital mortality, 1.2%). The median survival times in groups A-E were 27, 32, 19, 16 and 22 months, respectively. Conclusions: Chest wall resection offers immediate relief in the case of severe pain and unpleasant sequelae of ulceration. Moreover, it contributes to substantial long-term survival. This, in particular, applies to local recurrence after breast cancer. (C) 2001 Elsevier Science B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available